C14H17BrN2
293.2 g/mol
의약 중간체위험
5-bromo-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-Indole
CAS143322-57-0EC422-390-5
용도 분류
의약 중간체
화합물 분류
헤테로사이클
주요 용도
의약 중간체
This compound is a pyrrolidinylmethylindole and cyclized tryptamine that acts as a serotonin receptor agonist. It has been studied as an analogue and trace impurity of the antimigraine drug eletriptan.
Pharmaceutical intermediate for active pharmaceutical ingredientsReference standard or impurity for eletriptan research
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 143322-57-0
관련 화합물
용도 관련동일 용도
{3-[(tert-butoxy)carbonyl]phenyl}boronic acid
CAS220210-56-0
Pharmaceutical intermediate for APIs
용도 관련동일 용도
4-Amino-5-chloro-2-methoxybenzoic acid
CAS7206-70-4
Pharmaceutical intermediate for APIs
용도 관련동일 용도
Methyl (2R)-2-{[(tert-butoxy)carbonyl]amino}-3-iodopropanoate
CAS93267-04-0
Pharmaceutical intermediate for APIs
참고동일 카테고리
Fmoc-D-Aph(tBuCbm)-OH
CAS1433975-21-3
Pharmaceutical intermediate for peptide synthesis
참고동일 카테고리
Tert-butyl N-[(3S,4R)-3-fluoropiperidin-4-yl]carbamate
CAS1434126-99-4
Pharmaceutical intermediate for drug synthesis
참고동일 카테고리
2-Chloro-3-methylthiophene
CAS14345-97-2
pharmaceutical intermediate
참고동일 카테고리
2-[1-[(2~{r})-2-(2-Methoxyphenyl)-2-(Oxan-4-Yloxy)ethyl]-5-Methyl-6-(1,3-Oxazol-2-Yl)-2,4-Bis(Oxidanylidene)thieno[2,3-D]pyrimidin-3-Yl]-2-Methyl-Propanamide
CAS1434639-57-2
Pharmaceutical intermediate for drug synthesis
안전 참조
위험
H302Harmful if swallowed
H317May cause an allergic skin reaction
H332Harmful if inhaled
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
H318Causes serious eye damage
H361Suspected of damaging fertility or the unborn child
H370Causes damage to organs
식별자
IUPAC 이름
5-bromo-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole
InChIKey
JCXOJXALBTZEFE-GFCCVEGCSA-N
SMILES
CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)Br
동의어 목록 (16)
- Eletriptan Impurity 9